Tamac, Vimelda .

HRN: 28-54-68  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/10/2026
CEFUROXIME 500MG (TAB)
04/10/2026
04/16/2026
ORAL
500mg
BID
UTI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: